Cargando…
Clinical study to compare the efficacy and safety of casirivimab & imdevimab, remdesivir, and favipravir in hospitalized COVID-19 patients
BACKGROUND: Corona Virus disease - 2019 (COVID-19) disease induces scientific research to find a control to this pandemic from 2020 year up to now. Recently, various advances in pharmacotherapy against COVID-19 have emerged. OBJECTIVES: To compare the efficacy and safety of antibodies cocktail (casi...
Autores principales: | Hegazy, Sahar K., Tharwat, Samar, Hassan, Ahmed H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169321/ https://www.ncbi.nlm.nih.gov/pubmed/37220480 http://dx.doi.org/10.1016/j.jcvp.2023.100151 |
Ejemplares similares
-
Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients
por: Hegazy, Sahar K., et al.
Publicado: (2023) -
Retraction to “Study to compare the effect of casirivimab and imdevimab, remdesivir, and favipiravir on progression and multi-organ function of hospitalized COVID-19 patients”
por: Hegazy, Sahar K., et al.
Publicado: (2023) -
Casirivimab and imdevimab for COVID-19
Publicado: (2022) -
Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience
por: Moriello, Nicola Schiano, et al.
Publicado: (2023) -
Casirivimab/Imdevimab: First Approval
por: Deeks, Emma D.
Publicado: (2021)